Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia

Inclusion Criteria: * Patients with mild iron deficiency anemia Exclusion Criteria: * Patients with anemia caused by conditions other than iron deficiency * Patients with abnormal laboratory test values at screening for C-reactive protein, Serum phosphorus, Aspartate aminotransferase, Alanine aminotransferase, Total bilirubin * Patients with liver, kidney or circulatory system disease * Patients with a history or present illness that is a malignant tumor or autoimmune disease * Patients who underwent intravenous administration of an iron preparation, administration of an erythropoiesis stimulation agent or blood transfusion within 8 weeks before the screening * Patients who underwent oral administration of an iron preparation (including an over-the-counter drug or supplement) within 4 weeks before the screening